Username
Password
Forgot your username?
Forgot your password?
Create an account
Home
|
About Us
|
Contact Us
FDA Calendar
FDA Calendar
How To Use The FDA Calendar To Invest
Key Tips On Using The FDA Calendar
Articles
Featured Content
FDA News and Approvals
Most Popular
Latest News
Breaking News
User Submitted Articles
Contribute an Article
GlobeNewswire
News and Analysis
About Us
Support
Help Desk
Sector News
FDA Approves Genentech’s Cotellic™ in Combination With Zelboraf®; FORUM Announces Removal of Partial Clinical Hold on Phase 3 Encenicline Program
Below is a look at some of the headlines for companies that made news in the healthcare sector on November 11, 2015.
» Read More
MediciNova Receives Notice of Allowance for New Patent Covering MN-221; FDA Grants TEVA Therapy Designation for SD-809
Below is a look at some of the headlines for companies that made news in the healthcare sector on November 10, 2015.
» Read More
Capricor Presents Positive Data from the DYNAMIC Clinical Trial; Collegium Announces FDA Tentative Approval for Xtampza(TM) ER
Below is a look at some of the headlines for companies that made news in the healthcare sector on November 9, 2015.
» Read More
BioMedReports.com
More Articles...
Macrocure Announces Results for Phase III Clinical Trial of CureXcell(R); Amgen and Cytokinetics Announce Positive Top-Line Results From COSMIC-HF Phase 2
Novavax Reports positive data from Phase 2 Trial of Quadrivalent Seasonal Influenza VLP
Loxo Oncology and University of Colorado Cancer Center confirm Clinical Validation for LOXO-101 Against TRK Fusion Cancer
Active Stocks: Catalyst Pharmaceuticals, Can-Fite BioPharma, Acasti Pharmaceuticals, Northwest Biotherapeutics, Actavis
<<
Start
<
Prev
1
2
3
4
5
6
7
8
9
10
Next
>
End
>>
Page 8 of 877
Newsletter
